摘要
Background: A new method of immune-based therapies has been made and applied on multiple sclerosis patients in last decades. Some of these treatments have a high efficacy and reasonable side effects. In slowing disease progression, present treatments have significant limitations, but often associated with significant adverse effects of immunosuppression, with having a bit low capability to counter the disability. Methods: This is a review meta-analysis of treatment of multiple sclerosis. Results: Thus a valuable aim for multiple sclerosis clinical research is to introduce more effective therapies. Conclusion: It is absolutely necessary to increase the individualized therapy planes development in respect to make better planes to disease-modifying treatments.
Background: A new method of immune-based therapies has been made and applied on multiple sclerosis patients in last decades. Some of these treatments have a high efficacy and reasonable side effects. In slowing disease progression, present treatments have significant limitations, but often associated with significant adverse effects of immunosuppression, with having a bit low capability to counter the disability. Methods: This is a review meta-analysis of treatment of multiple sclerosis. Results: Thus a valuable aim for multiple sclerosis clinical research is to introduce more effective therapies. Conclusion: It is absolutely necessary to increase the individualized therapy planes development in respect to make better planes to disease-modifying treatments.
作者
M. Nadeem
O. Mufti
I. Ahsan
R. Naheed
S. M. Faheem
M. Nadeem;O. Mufti;I. Ahsan;R. Naheed;S. M. Faheem(Muhammad Nadeem MBBS, SUNY, Buffalo, NY, USA;Owais Mufti MD, SUNY, Buffalo, NY, USA;Irfan Ahsan MD, Abington Memorial Hospital, Abington, PA, USA;Rabia Naheed MBBS, Fatima Memorial Hospital, Lahore, Pakistan;Sheikh Muhammad Faheem MBBS, University of IOWA Hospital, Iowa City, IA, USA)
